A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer

OBJECTIVE: To determine if patients with advanced prostate cancer carrying a polymorphism that codes for a more active testosterone transporter have less durable responses to androgen-deprivation therapy (ADT) than patients not carrying this polymorphism. PATIENTS AND METHODS: We previously determin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sharifi, Nima, Hamada, Akinobu, Sissung, Tristan, Danesi, Romano, Venzon, David, Baum, Caitlin, Gulley, James L., Price, Douglas K., Dahut, William L., Figg, William D.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2574946/
https://ncbi.nlm.nih.gov/pubmed/18537956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2008.07629.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares